Aquyre Biosciences, Inc. — Form D/A
Aquyre Biosciences, Inc. of WESTON, MA, a company, filed a Form D amendment with the SEC on 2022-05-13. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other.
Offering
- Filed: 2022-05-13
- Form: D/A
- Accession: 0001887377-22-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Remaining: $5
- Investors: 3
- Date of first sale: 2022-02-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-436532
Issuer
- Name: Aquyre Biosciences, Inc.
- CIK: 0001887377
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 133 BOSTON POST ROAD, WESTON, MA, 02493
- Phone: (774) 220-7040
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Thierry Thaure | Director | San Jose, CA |
| Thierry Thaure | Executive Officer | San Jose, CA |
| Aurelio Fernandez | Director | Austin, TX |
| Cosme James Ordonez | Director | Weston, MA |
| Floyd Samuel Eberts, III | Director | Weston, MA |
| Floyd Samuel Eberts, III | Executive Officer | Weston, MA |
| Ronald James Sorenson | Director | Weston, MA |
| Claude Samuel Boccara | Executive Officer | Weston, MA |
| Richard Samuel McCann | Executive Officer | Weston, MA |
| Bertrand Samuel Le Conte Chrestien de Poly | Director | Weston, MA |
| Bertrand Samuel Le Conte Chrestien de Poly | Executive Officer | Weston, MA |
| Gregory Samuel Bowles | Executive Officer | Weston, MA |
| Francois Samuel Grammont | Executive Officer | Weston, MA |
| Aurelio James Fernandez | Director | Weston, MA |
| Bertrand Le Conte Chrestien de Poly | Director | Boston, MA |
| Bertrand Le Conte Chrestien de Poly | Executive Officer | Boston, MA |
| Aldo Maccari | Director | Boston, MA |
| Ari Azhir | Director | Boston, MA |
| Michael Albin | Director | EXTON, PA |
Other filings by this issuer (5)
More